Journal of Ophthalmic and Vision Research
ISSN: 2008-322X
The latest research in clinical ophthalmology and the science of vision.
Topical Calcineurin Inhibitors: Expanding Indications for Corneal and Ocular Surface Inflammation
Published date: Oct 24 2019
Journal Title: Journal of Ophthalmic and Vision Research
Issue title: October–December 2019, Volume 14, Issue 4
Pages: 398–399
Authors:
Abstract:
This is an Editorial and does not have an abstract.
References:
1. Lee YJ, Kim SW, Seo KY. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Am J Ophthalmol 2013;155:804–813.
2. Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y, et al. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology 2008;115:988–992.
3. Ghaffari R, Ghassemi H, Zarei-Ghanavati M, Latifi G, Dehghani S, Haq Z, et al. Tacrolimus eye drops as adjunct therapy in severe corneal endothelial rejection refractory to corticosteroids. Cornea 2017;36:1195–1199.
4. Hashemian MN, Latifi G, Ghaffari R, Ghassemi H, Zarei- Ghanavati M, Mohammadi SF, et al. Topical tacrolimus as adjuvant therapy to corticosteroids in acute endothelial graft rejection after penetrating keratoplasty: a randomized controlled trial. Cornea 2018;37:307–312.
5. Kheirkhah A, Zavareh M, Farzbod F, Mahbod M, Behrouz MJ. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond) 2011;25:872–880.
6. Akbari A, Soltani Moghadam R, Elmi R, Nosrati A, Taghiabadi E, Aghdami, N. Topical Tacrolimus as an adjunct to conventional therapy for herpetic stromal keratitis: a randomized clinical trial. J Ophthalmic Vis Res 2019;14.
7. Chatterjee A, Bandyopadhyay S, Bandyopadhyay SK. Efficacy, safety, and steroid sparing effect of topical cyclosporine a 0.05% in vernal keratoconjunctivitis in Indian children. J Ophthalmic Vis Res 2019;14.
